4th Annual MarketsandMarkets

Next-Gen Microbiome and Probiotics Conference

16th - 17th June 2022

Double Tree by Hilton San Diego- Mission Valley

The ecology of human microbiome is known to be associated with both phenotype and environment. With the increasing focus on the development of human microbiome therapies and probiotics product &drug development various small innovative players are operating in the market.

However, inadequate research and regulatory policies in the human microbiome are some of the factors which restrain the progress. Learn about microbial innovation and applying the new microbiome findings along with the regulatory pathways for better therapeutic development. Also, witness discussions on Microbiome vs probiotics and the link between them.

Connect with biotech, pharma, academicians and investors at 4th Annual Next Gen Microbiome and Probiotics Conference on 16th - 17th June 2022 in San Diego, USA, discussing the most ingenious research and technological advances. Key sessions on Applying new microbiome findings, regulatory updates, brandng and marketing of probiotics along with discussion on effective translation from R& D to commercialization.

CO-LOCATED CONFERENCES

7th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference

WHAT TO EXPECT

  • Microbial Innovations- Applying new microbiome findings
  • Regulatory updates
  • Microbiome as a science and its clinical applications- skin, gut & women’s health
  • Pediatrics and infant health
  • Analyzing the concept of Probiotics
  • Strain Identification
  • R & D to commercialization- effectively translating research into commercialization
  • Right branding and marketing of probiotics products
  • The Future of Probiotics in the Consumer Marketplace

Medical Directors, Principal Investigators, Methodologists, and other clinical research professionals from pharmaceuticals, nutraceuticals and therapeutics-based organizations from the departments of:

  • Microbiome discovery
  • Department of Biochemistry and Immunology
  • Microbiome science
  • Microbiology
  • Biological Science
  • Gut Biology
  • Human microbiome

CONFERENCE AGENDA

Registration

08:15 - 08:55

Welcome note from MarketsandMarkets

08:55 - 09:00

Opening remarks from the Chairman

 Julius Goepp

Julius Goepp, CEO, Evimero

09:00 - 09:05

Keynote Presentation: - A Taxonomy-Agnostic Approach to Targeted Microbiome Therapeutics

 Julius Goepp

Julius Goepp, CEO, Evimero

09:05 - 09:40

APPLYING NEW MICROBIOME FINDING & REGULATORY UPDATES

Species-level 16S Microbiome by Simultaneous, Weighted Analysis of Hypervariable Domains 1-8

Seth Crosby

Seth Crosby, Director, Research Collaborations, Washington University School of Medicine

09:40 - 10:15

Back to Health - An Evolutionary Biology Perspective on the Skin Microbiome

Larry Weiss

Larry Weiss, CEO & Founder, Symbiome

10:15 - 10:50

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:50 - 11:35

Tissue and Circulating Microbiome - Application for oncology

Sandrine Miller-Montgomery

Sandrine Miller-Montgomery, Co-Founder, President and CEO, Micronoma

11:35 - 12:10

Panel Discussion- Updates in microbiome research and findings- Perspective from skin, gut and woman’s health expert

12:10 - 12:45

What the Heck is going on in Kid s Guts?

Madeline Lauf

Madeline Lauf, Founder, Begin Health

12:45 - 13:20

Lunch and Poster Presentation | One-to-One Networking Meetings

13:20 - 14:20

A robust in vivo microbiome testing protocol: testing the effect of microbiome products, with a quantitative readout to support with claims substantiation

Oliver Worsley

Oliver Worsley, Founder, Sequential Skin

14:20 - 14:55

ANALYZING THE CONCEPT OF PROBIOTICS

Host cell-receptor targeted bioengineered probiotics against enteric infection and IBD

Arun Bhunia

Arun Bhunia, Professor of Food Microbiology, Chair,, Purdue Institute of Inflammation, Immunology and Infectious Disease

14:55 - 15:30

Understanding Probiotic Cell Health Using Flow Cytometry

Dana Buckman

Dana Buckman, CEO, BioForm Solutions

15:30 - 16:05

Afternoon Refreshments and Poster Presentation | One-to-One Networking Meetings

16:05 - 16:45

The Evolution of Probiotics for Consumer Health Products

Peter Leighton

Peter Leighton, CEO, ProSperity Bioscience

16:45 - 17:20

Closing remarks from the Chairman

17:25 - 17:30

Drinks Reception & Networking End of Day 1

17:25 - 17:25

Registration

08:15 - 08:55

Welcome note from MarketsandMarkets

08:55 - 09:00

Opening Remarks from the Chairman

09:00 - 09:05

EFFECTIVELY TRANSLATING MICROBIOME RESEARCH INTO PRODUCTS

Keynote Presentation: How to modulate the oral microbiome for systemic health

 Emily Stein

Emily Stein, CEO, Primal Health Inc.

09:05 - 09:40

Multi-omic Systems Biology approach to improved diagnostics and therapeutics in chronic diseases, cancers, and aging

Ryan Toma

Ryan Toma, Research Scientist, Viome

09:40 - 10:15

Monitoring the Skin Microbiome

 Nicole M. Scott

Nicole M. Scott, CEO and Founder, Cybele Microbiome

10:15 - 10:50

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:50 - 11:35

Precise Microbiome Editing to Change How We Treat Chronic Bacterial Diseases

Yug Varma

Yug Varma, CEO, Phi Therapeutics

11:35 - 12:10

Panel Discussion- Where is Microbiome Science today – Closer to Darwin, Newton, or Heisenberg

12:10 - 12:50

Live Probiotics – Topical application for the skin

 Maya Ivanjesku

Maya Ivanjesku, Chief Scientific Officer, Dakota Biotech

12:50 - 13:10

Lunch and Poster Presentation | One-to-One Networking Meetings

13:10 - 13:10

CONFERENCE SPEAKERS

ADVISORS

 Julius Goepp

Julius Goepp

CEO, Evimero

 Emily Stein

Emily Stein

CEO, Primal Health Inc.

Yug Varma

Yug Varma

CEO, Phi Therapeutics

 Nicole M. Scott

Nicole M. Scott

CEO and Founder, Cybele Microbiome

SPEAKERS

 Julius Goepp

Julius Goepp

CEO, Evimero

 Emily Stein

Emily Stein

CEO, Primal Health Inc.

Yug Varma

Yug Varma

CEO, Phi Therapeutics

 Nicole M. Scott

Nicole M. Scott

CEO and Founder, Cybele Microbiome

Maya Ivanjesku

Maya Ivanjesku

Chief Scientific Officer, M2B Pharma

Arun Bhunia

Arun Bhunia

Professor of Food Microbiology, Chair,, Purdue Institute of Inflammation, Immunology and Infectious Disease

Ryan Toma

Ryan Toma

Research Scientist, Viome

Madeline Lauf

Madeline Lauf

Founder, Begin Health

Larry Weiss

Larry Weiss

CEO & Founder, Symbiome

Sandrine Miller-Montgomery

Sandrine Miller-Montgomery

Co-Founder, President and CEO, Micronoma

Dana Buckman

Dana Buckman

CEO, BioForm Solutions

ENQUIRE NOW

SPONSORS

PARTNERS

LOCATION

Venue

Double Tree by Hilton San Diego- Mission Valley

PAST EVENT GALLERY